Skip to main content
. Author manuscript; available in PMC: 2019 Oct 8.
Published in final edited form as: Vaccine. 2018 Sep 14;36(42):6345–6353. doi: 10.1016/j.vaccine.2018.07.032

Table 4:

Sera competition binding studies using ELISA.

Percent competition at 1:50 dilution of week 22 seraa
b12 F105 VRC-PG04 VRC01 PGT128
Group1 10±2 38±1 9±2 14±2 2±1
Group2 12±0.5 26±2 14±1 12±1 4±2
Group3 17±2 28±2 22±1 11±1 14±1
Group4 42±2b 57±1b 26±2 21±1 15±1
Group5 21±2 29±1 26±1 18±2 14±1
Group6 19±0.5 18 14±1 18±1 4±1
a

Data shown represent percent competition from two independent experiments and are represented as mean±SE.

b

Percent competition for Group 4 sera with antibodies b12 and F105 is significantly higher compared to other groups, P<0.01 (individual means compared by Welch’s t-test).